AMGEN

AMGEN

Displaying 10 out of 34 results

  1. FILE PHOTO: An Amgen sign is seen at the company's office in South San Francisco

    FDA approves Amgen's biosimilar to J&J's rheumatoid arthritis drug

    The U.S. Food and Drug Administration on Friday approved Amgen Inc's biosimilar copy of Johnson & Johnson's blockbuster rheumatoid arthritis drug, ...
  2. File photo of an Amgen sign at the company's office in South San Francisco

    Pharmacy benefits manager Abarca inks discount deal for Amgen's Enbrel

    Abarca, a small Puerto Rico-based pharmacy benefits manager, said on Tuesday Amgen Inc had agreed to give its health insurer clients an additional ...
  3. FILE PHOTO: Switzerland's national flag flies in front of the logo of Swiss drugmaker Novartis

    Novartis takes on Sanofi, Amgen with US$9.7 billion takeover of heart drug maker

    Novartis AG is buying U.S. biotechnology company The Medicines Co for about US$9.7 billion, the Swiss drugmaker said on Sunday, as it seeks to ...
  4. New Content Item

    Novartis gets US nod for long-delayed Amgen copycat

  5. FILE PHOTO: An Amgen sign is seen at the company's office in South San Francisco

    Amgen to take 20.5per cent stake in BeiGene to expand in China

    Amgen Inc said on Thursday it will acquire a 20.5per cent stake in BeiGene Ltd in a deal that will enable the California-based biotechnology ...
  6. File photo of an Amgen sign at the company's office in South San Francisco

    Amgen posts higher biosimilar sales, ends neuroscience program

    Amgen Inc on Tuesday said competition for its older drugs sent third-quarter revenue down 3per cent, but biosimilar sales were strong and the ...
  7. An Amgen sign is seen at the company's office in South San Francisco

    Amgen sets one lower list price for its cholesterol drug

    Drugmaker Amgen Inc said on Thursday that starting next year, its official list price for cholesterol drug Repatha will be the lower price it ...
  8. New Content Item

    Amgen drug shrinks lung cancer tumors in half of patients: study

  9. File photo of an Amgen sign at the company's office in South San Francisco

    Patent court to review Alexion's Soliris patents on Amgen challenge: filings

    The U.S. patent office will review three patents on Alexion Pharmaceuticals Inc's drug Soliris, after rival Amgen Inc filed a petition challenging ...